9: The "Disruptors" and the Role of Innovation in Drug Pricing
Sep 17, 2020•22 min•Ep. 9
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The Trump administration’s most recent executive order tackles drug pricing in the United States and replaces an order that was supposed to be implemented on August 24, 2020. In this podcast episode, Eric Levin, CEO of Scripta Insights, discusses with Drug Topics® how “positive disruption” from private companies and innovators are better positioned to confront challenges within the pharmaceutical industry.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast